Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05777759 · ClinicalTrials.gov registry record · NA
Safety and Effectiveness of Restylane Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile
A NA study, sponsored by Galderma R&D.
- Completed
- Registry status
- NA
- Development phase
- 175
- Enrollment target
NCT05777759 is a NA study that has completed, run by Galderma R&D. The registered enrollment target is 175 participants.
The verdict
NCT05777759, a NA study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- NA
- Development phase
- 175 participants
- Enrollment target
Study Summary
The primary objective of the study was to demonstrate non-inferiority of Restylane Lyft with Lidocaine versus a comparator-control for augmentation of the chin region to improve the chin profile.
Interventions
- DEVICE Restylane Lyft with Lidocaine
- DEVICE Juvederm Voluma XC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2023-03-22 |
| Est. Completion | 2024-07-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05777759
The ClinicalTrials.gov registry entry for NCT05777759 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Restylane Lyft with Lidocaine is the first listed.
NCT05777759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05777759 about?
NCT05777759 is a clinical study titled "Safety and Effectiveness of Restylane Lyft With Lidocaine for Augmentation of the Chin Region to Improve the Chin Profile". The primary objective of the study was to demonstrate non-inferiority of Restylane Lyft with Lidocaine versus a comparator-control for augmentation of the chin region to improve the chin profile.
What is the current status of trial NCT05777759?
This trial is currently completed. It is a NA study. The enrollment target is 175 participants. The study started on 2023-03-22. Estimated completion is 2024-07-10.
What interventions are being tested in trial NCT05777759?
The interventions under investigation include: Restylane Lyft with Lidocaine (DEVICE), Juvederm Voluma XC (DEVICE).
Who is sponsoring clinical trial NCT05777759?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.